-

2020 On-site Completes Observational Study that Confirms Eye Exams in Mobile Settings Have Same Results as In-Office Exams

BOSTON--(BUSINESS WIRE)--2020 On-site, a Boston-based mobile optometry company whose mission is to expand access to high-quality vision care including clinical research, has completed its observational study to assess the quality of subjective refraction, autorefraction, and keratometry measurements in a mobile eye setting. The study, which was completed during a month-long period, found there is no statistically significant difference between data retrieved in the mobile vision clinic setting as compared to data retrieved through an in-office exam.

The study consisted of 20 subjects ages 18 through 60 who received eye examinations in both an office setting and onboard the mobile vision clinic within a 30-minute period. In each testing location, patients were given autorefraction, keratometry, and subjective refraction testing, allowing investigators to collect 10 different data points on 40 unique eyes. Over 400 pieces of data were obtained for comparative analysis.

“This study tells us that mobile eye evaluations produce results that are just as accurate as an in-office examination,” says Dr. Debi Sarma, OD, 2020 On-site optometrist and principal investigator.

This validation of mobile optometry as a delivery system for reliable, repeatable, and accurate eye care benefits patients across the country who need specialty vision services closer to home, either routinely or in clinical research settings.

“The implications of this study are significant. Mobile vision clinics have the ability to travel great distances to provide care. Terrain, altitude, temperature, and road conditions are all considerations when appropriately managing the optometric equipment on board,” Dr. Sarma adds. “This study not only highlights the caliber of the machines on the mobile clinics, but also the years of experience and innovation it takes to obtain high-quality data as we provide care across the country.”

Each of 2020 On-site’s mobile vision clinics travel almost 20,000 miles per year, seeing between 500 and 700 patients per month. The results from this study enhance the company’s mission to improve access to high-quality eye exams for individuals living in geographically disparate areas in need of equitable care.

About 2020 On-site:

Founded in 2014, 2020 On-site’s mobile vision clinics and world-class eye care team have provided vision care to over 75,000 patients at their workplaces, schools, and neighborhoods. In May 2020, services were expanded to include vital access to clinical trial assessments and tests, bringing updated and uniquely equipped mobile clinics directly to trial participants. Named one of Inc. Magazine's Fastest-Growing Companies in 2018, 2020 On-site is disrupting the delivery of health care and empowers the Life Sciences research field. For more information, visit 2020onsite.com or to learn more about 2020 On-site’s clinical trials capabilities, please visit 2020onsite.com/en/clinicalprograms or email clinicaltrials@2020onsite.com.

Contacts

2020 On-site


Release Summary
2020 On-site has completed its observational study to assess the quality of data in a mobile eye setting.
Release Versions

Contacts

Social Media Profiles
More News From 2020 On-site

20/20 Onsite Recognized by TITAN Health Awards for Transforming Healthcare Through Patient-Centric, Point-of-Need Ophthalmic Assessments

BOSTON--(BUSINESS WIRE)--20/20 Onsite has been named a Silver Winner in the 2025 TITAN Health Awards in Provider & Services - Healthcare....

20/20 Onsite Receives Safety Excellence Award, Reinforcing Commitment to Unmatched Clinical Trial Support

BOSTON--(BUSINESS WIRE)--20/20 Onsite is proud to announce its recognition with the Safety Excellence Award by Whip Around....

20/20 Onsite Executives Recognized for Global Business Achievements in the 2024 TITAN Women In Business Awards

BOSTON--(BUSINESS WIRE)--20/20 Onsite is proud to announce that two of its executives, Sonali Bloom, CEO, and Jessica McKenzie Mays, Vice President of Life Sciences, have been named 2024 Female Executives of the Year by the TITAN Women in Business Awards, presented by the International Awards Associate (IAA). Bloom received the Platinum Award for CEO of the Year, while McKenzie Mays was honored with the Platinum Award for Innovative Executive of the Year. These prestigious awards recognize thei...
Back to Newsroom